Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...
US Commerce Secretary Howard Lutnick‘s hedge fund Cantor Fitzgerald LP increased the firm’s exposure to Bitcoin (CRYPTO: BTC) ...
Senate Commerce Committee chair Ted Cruz said Lutnick will focus on issues including expanding commercial access to wireless ...
Cantor Fitzgerald raised the firm’s price target on Five9 (FIVN) to $57 from $46 and keeps an Overweight rating on the shares. Give9 reported ...
Hosted on MSN2d
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN)Fintel reports that on February 19, 2025, Cantor Fitzgerald downgraded their outlook for Supernus Pharmaceuticals ...
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by equities research analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating in a research report issued ...
Cantor Fitzgerald lowered the firm’s price target on Nice (NICE) to $161 from $176 and keeps a Neutral rating on the shares. Nice reported ...
“As you can imagine, the pain we suffered with Gary and 657 of my other friends and colleagues at Cantor Fitzgerald were killed on 9/11,” Lutnick said during his confirmation hearing before ...
Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback